Clinical Trials Browser

Hypersensitivity × amminedichloro(2-methylpyridine)platinum(II) × Clear all

NCT00116610 2009-01-21

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Phase 2 Completed

Hypersensitivity, Recurrence, Small Cell Lung Carcinoma